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Natural killer (NK) cells are large granular lymphocytes attributed with the ability to lyse certain tumour 
cells. Previous studies on NK cells have demonstrated only an in vivo suppression of NK cell activity by 
17/Loestradiol. The suppressive action of oestrogen on other peroxidase-containing leukocytes by virtue of 
its redox potential has already been documented. In the present study oestrogen suppressed NK cell cyto- 
lysis in vitro (determined by the release of [SICr]chromate from radiolabelled cells) in a dose-dependent man- 
ner @ < 0.01). Parallel experiments demonstrated a similar reduction in NK cell luminol chemiluminescence 
during activation by K562 tumour cells. Therefore, it would appear that there may be an association be- 
tween NK cell lysis and their peroxidase/oxygenase activity. 
Estrogen NK cell Peroxidase Cytolysis inhibition 
1. INTRODUCTION 
Natural killer (NK) cells constitute an important 
component of the immune surveillance system 
against malignant neoplasms, restraining both 
their growth and dissemination. These large, 
granular lymphocytes are present in particularly 
high numbers in the spleen and lymph nodes where 
they exhibit target specificity for a number of dif- 
ferent tumours. The NK cells are widely 
distributed throughout the body where, in addition 
to neoplastic cell surveillance, they have been 
associated with a number of other functions in- 
cluding apoptosis of effete cells, graft rejection, 
and activation in viral and bacterial infections. 
They have also been implicated in certain autoim- 
mune disorders and connective tissue diseases. 
It is well established that oestrogens can in- 
fluence many different parameters of the immune 
response although there does not appear to be a 
specific leukocyte receptor for this group of steroid 
sex hormones. Hence an alternative mode of ac- 
tion upon leukocytes must be postulated. 
Oestrogens, by virtue of their phenolic A ring, are 
capable of undergoing oxidation. Their oxidation 
potential is of the order of + 500 mV [l] and as 
such can be oxidised by peroxidase; this results in 
the formation of catecholic oestrogens [2], The 
synthetic oestrogen, fosfestrol, has been shown to 
be a substrate for the peroxidase/oxygenase 
systems in both polymorphoneutrophils [l] and 
monocytes (31. 
Treatment of mice with high concentrations of 
17,&oestradiol depletes the NK cell population 
[4-61. Initially this was attributed to a decreased 
marrow space although subsequent work by the 
same group [7] suggested a direct effect upon the 
NK cells. Diethylstilboestrol similarly reduced 
murine NK cell activity when given neonatally and 
caused the animals to have an increased tumour 
susceptibility [8]. 
The mechanism by which NK cells lyse target 
cells is unclear. Proteases, esterases and 
phospholipases have all been implicated, perhaps 
by injecting these lytic enzymes directly through 
their microvilli into the target cell. Peroxidase, or 
possibly oxygenase activity, has been identified by 
chemiluminescence studies in the NK cells [9] and 
it is possible that such enzyme systems may play a 
direct role in killing by generating active free 
radicals of oxygen. 
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2. MATERIALS AND METHODS 
Venous blood was removed at the same time 
each day (8-9 a.m.) from 8 healthy volunteers, 
aged 22-39 years, and mixed immediately with 
preservative-free heparin - 200 U heparin in 5 ml 
Dulbecco’s phosphate-buffered saline (PBS) per 
50 ml blood. Mononuclear leukocytes were re- 
moved by density centrifugation at 400 x g for 
30 min on Ficoll-Hypaque (Pharmacia). The cells 
were washed twice with medium RPM1 1634 con- 
taining 5% foetal calf serum (Gibco Biocult), buff- 
ered to pH 7.4 with 0.02 M Hepes, and then in- 
cubated at 37’C for 1 h in plastic flasks which had 
been pre-incubated for I5 min with autologous 
serum to remove monocytes by adherence. The 
B-lymphocytes were then depleted by passage 
through a 10 cm nylon wool column. The resultant 
cells were found to be 95% viable using trypan 
blue exclusion and also after 5 h incubation with 
fosfestrol there was no decrease in cell viability. 
of diethylstilboestrol phosphate) was examined 
over the concentration range 10-6-10-3 M. This 
synthetic oestrogen is readily water soluble and 
permitted a wide range of concentrations in 
aqueous media. Further, hydrolysis of the 
phosphate group is unnecessary to permit oxida- 
tion of the phenolic ring which is in contrast to the 
interaction of this hormone with specific oestrogen 
nuclear receptors. 
To measure cytolysis of target cells, the K562 
cells were first incubated at 37°C for 1 h with a 
solution of [%r]chromate (sodium chromate in 
aqueous solution containing 0.9% NaCl: specific 
activity of “Cr, 350-600 mCi/mg chromium); 
100 Ci [51Cr]chromate in 1 ml medium RPM1 
1634, containing 5 x lo6 cells. The cells were then 
washed 3 times with culture medium and again 
suspended in medium RPM1 1634 containing 5% 
foetal calf serum. 
K562 cells, an erythroid leukaemic line, were 
cultured in medium RPM1 1634 containing 5% 
foetal calf serum (Gibco Biocult), penicillin (100 
units . ml-‘) and streptomycin (100 ur - ml-‘); 
0.02% glutamine was added every second day. 
These target cells were used for both luminometry 
and cytolysis resuspended in PBS at a ratio of 10 
lymphocytes to 1 K562 cell. 
The lymphocytes, at 1 x 10’ cells in 250 ~1, were 
suspended in Gey’s solution and allowed to dark 
adapt in borax glass tubes for 30 min at 36°C in a 
Packard Picolite luminometer. Luminol (59 pl) 
was added, to give a final concentration of 
10e4 M, and 50~1 K562 cells were injected. 
Chemiluminescence was measured by 30 s sequen- 
tial counts and peak chemiluminescence was 
reached from 30 to 40 min. For each individual’s 
cells, counting was commenced 5 min before the 
peak was reached and then for a further 10 min. 
All experiments were carried out in triplicate. Con- 
trols containing either lymphocytes alone or K562 
cells alone produced no chemiluminescence. When 
K562 cells were added to monocytes there was 
negligible chemiluminescence although the 
separated monocyte fraction did produce 
chemiluminescence on addition of opsonised 
zymosan. Likewise when zymosan was added to 
the lymphocytes a negligible response was seen. 
Cytolysis was performed by incubating 200 ~1 
lymphocytes with 200,ul K562 cells together with 
either 100~1 PBS or fosfestrol in PBS, at 37°C in 
a humidified atmosphere of 5% COz: 95% air for 
5 h. All incubations were performed in triplicate. 
At the end of this time, 500 ~1 medium RPM1 1634 
was added and the tubes then centrifuged at 400 x 
g for 10 min. Using a gamma spectrometer, the 
radioactivity was counted in both a 500 ml aliquot 
of supernatant and the remaining 500111 of 
medium plus cells. 
Spontaneous release of [5’Cr]chromate from 
K562 cells into the supernatant was measured when 
these cells were incubated in the absence of lym- 
phocytes. To determine maximal release of 
[51Cr]chromate, 3 detergents were evaluated: 
Triton X-100, Lissapol NX and sodium deox- 
ycholate. Of these detergents, sodium deox- 
ycholate was found to give optimal release and 
therefore used for all subsequent experiments. 
It has been conventional to calculate cytolysis by 
the formula: 
(Rexp - Rsd % cytolysis = (Rmax _ Rsp) x 100 
where Rexp is the radioactivity in the supernatant of 
experimental tubes, R,, the spontaneously released 
radioactivity and R,, the maximally released 
radioactivity. 
The effect of including fosfestrol (disodium salt However, such an equation does not take 
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cognisence of the fact that lymphocytes may take 
up [‘rCr]chromate from the medium once this has 
been released from the K562 cells. This would give 
an underestimate of cytolysis in the experimental 
tubes and it is therefore desirable to introduce a 
further factor, the uptake constant (K,), giving the 
corrected formula. 
% cytolysis = (RexP ’ Ku) - RsP 
R - Rs, 
x 100 
max 
The magnitude of this correction factor was 
found to be 1.04 for the experimental conditions 
described, where supernatant counts exceeded 1 x 
lo5 in 100 s for a 500 ,A volume of lymphocytes, at 
1 x 10’ cells-ml-‘. 
The effect of including fosfestrol, at 
10-6-10-3 M, was investigated by pre-incubating 
the mononuclear cells for 10 min with the 
oestrogen prior to addition of the K562 target cells. 
Controls were examined containing no fosfestrol. 
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Fig. 1. Effect of increasing concentrations of fosfestrol 
on the luminol chemiluminescence of NK cells. Values 
are expressed as a percentage of control containing no 
oestrogen. 
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Fig.2. Effect of increasing concentrations of fosfestrol 
measured as “Cr release from K562 target cells. Values 
for NK cell cytotoxicity are expressed as a percentage of 
controls. 
3. RESULTS 
Over the concentrations of fosfestrol examined 
there was a progressive decrease in che- 
miluminescence indicating that the oestrogen could 
interact with the peroxidase system of the NK-cell 
(fig.1). The correlation coefficient showed this to 
be highly significant p < 0.01. 
The results of these cytolysis experiments how 
a significant reduction in cell killing (r, < 0.01) with 
increasing concentrations of fosfestrol (fig.2) and 
it is apparent hat the magnitude of this decrease is 
comparable to the diminution in peroxidase/ox- 
ygenase based chemiluminescence seen in fig.1. 
4. DISCUSSION 
Our data support the previous in vivo findings 
that oestrogen suppresses NK cell activity. By 
adopting an in vitro system it would seem that this 
is accomplished by a direct action upon the NK 
cells rather than indirectly, as was postulated either 
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by decreasing bone marrow space or by altering the 
NK cell/interferon pathway [7]. Depression of NK 
cell activity by oestrogen may partly account for 
sex differences in a variety of disorders but the ac- 
tions of progestogens and androgens must also be 
taken into account. 
Although the precise role of the peroxidase/ox- 
ygenase systems in the NK cell still requires 
elucidation the data indicate that this activity is 
obligatory for killing, either directly or indirectly. 
Under these circumstances the possibility is raised 
that the NK cell generates free oxygen radicals as 
part of its killing mechanism. 
The interacting of oestrogens with perox- 
idase/oxygenase enzyme systems represents a 
mechanism whereby these sex hormones can in- 
fluence leukocytes in the absence of specific 
receptors. 
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